Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Clarivate announces the acquisition of ProQuest, a software, data, and analytics provider to academic and research institutions. The total consideration stands at $5.3 billion and carries a 12-13x EV/EBITDA multiple (including synergies).

Clarivate: ProQuest Acquisition Accelerates The Compounding Potential

LONDON, June 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global Research Report which examines the ability of nations and institutions to respond to unexpected challenges or opportunities in science, medicine, technology and social sciences based on the diversity of their research activities and expertise. With the publication of, " Subject diversity in research portfolios", analysts at the Institute for Scientific Information (ISI)™ at Clarivate consider subject diversity in a research context and show trends in national and institutional research portfolios by examining publications from across the G71 and BRICK2 nations from 1981 – 2018.

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the pricing of its previously announced private offering (the "Offering") of $1.0 billion of 3.875% senior secured notes due 2028 (the "Secured Notes") and $1.0 billion of 4.875% senior notes due 2029 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes"). Interest on the Notes will be payable semi-annually on June 30 and December 30 of each year, beginning on December 30, 2021.

Clarivate Announces Pricing of Offering of $1.0 Billion Senior Secured Notes and $1.0 Billion Senior Notes

LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the commencement of a private offering (the "Offering") of $1.0 billion of senior secured notes due 2028 (the "Secured Notes") and $1.0 billion of senior notes due 2029 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes"). The Notes are expected to be issued by Clarivate Science Holdings Corporation (the "Issuer"), an indirect wholly-owned subsidiary of Clarivate, subject to market and other conditions.

Clarivate Announces Commencement of Offering of $1.0 Billion Senior Secured Notes and $1.0 Billion Senior Notes

LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the pricing of concurrent offerings of 38,461,538 ordinary shares at a price to the public of $26.00 per share, of which 28,846,154 ordinary shares are being offered by Clarivate and 9,615,384 ordinary shares are being offered by certain existing shareholders (the "Ordinary Share Offering"), and 12,500,000 5.25% Series A Mandatory Convertible preferred shares (the "convertible preferred shares") at a price to the public of $100 per share (the "Convertible Preferred Share Offering," and together with the Ordinary Share Offering, the "Offerings"). Certain existing shareholders have granted the underwriters of the Ordinary Share Offering a 30-day option to purchase up to an additional 5,769,230 ordinary shares.

Clarivate Announces Pricing of Offerings of Ordinary Shares and Convertible Preferred Shares

Atossa Genetics

Carver Bancorp

Clover Health Investments

Comtech Telecommunications

Dream Finders Homes

Viant Technology

SemiLEDs

NextDecade

United Natural Foods

The stock prices of ATOS, NEXT, LEDS, CARV, UNFI, CMTL, DSP, DFH, CLVT, and CLOV fell during intraday trading. Here is more information about it.

ATOS, NEXT, LEDS, CARV, UNFI, CMTL, DSP, DFH, CLVT, CLOV Stock Prices Fall Intraday

The analytics company announced two concurrent proposed stock offerings.

Why Clarivate Stock Dropped on Wednesday

LONDON, June 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that it has commenced concurrent proposed offerings of $750 million of ordinary shares, alongside which certain existing shareholders intend to offer $250 million of ordinary shares (the "Ordinary Share Offering"), and $1.25 billion of Series A Mandatory Convertible preferred shares (the "convertible preferred shares") (the "Convertible Preferred Share Offering," and together with the Ordinary Share Offering, the "Offerings"). Neither the completion of the Ordinary Share Offering nor the Convertible Preferred Share Offering is contingent upon completion of the other.

Clarivate Announces Proposed Offerings of Ordinary Shares and Convertible Preferred Shares

New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of its  COVID-19 Vaccine Availability and Medtech Impact Report which features retrospective, current and predictive analysis to forecast an estimate of the rate at which vaccination will occur in each country in 2021. The report found that, despite continued public health measures in 2021, it is expected that the emergence of multiple vaccines in late 2020 and the rollout of these vaccines globally will determine how healthcare markets recover in 2021 and beyond.

Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021

Explore IP to integrate Derwent World Patents Index™ global patent data to help organizations increase the marketability of technologies LONDON, June 3, 2021 /PRNewswire/ -- Clarivate Plc  (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today an exclusive commercial partnership with Explore IP to integrate Derwent™ patent data into its platform. The enhanced Derwent™ patent data will supplement Explore IP's data in an effort to enable businesses, creators, entrepreneurs and innovators discover intellectual property (IP) held by public sector institutions.

Clarivate Partners with Explore IP to Support Canadian Innovation

LONDON, May 26, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in June 2021. William Blair' s 41st Annual Growth Stock Conference on Wednesday, June 2, 2021 at 10:00 am Central Time.

Clarivate to Present at Upcoming Virtual Investor Conferences in June 2021

Europe leads with almost half of the world's best protected brands; and consumer brands dominate LONDON, May 26, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the first ever listing of Top 100 Best Protected Global Brands. The 2021 report identifies the most impactful and best protected brands in the world, measuring brand strength through the analysis of advanced and unified IP data including trademark information, global case law and digital domain name protection.

First Ever Clarivate Top 100 Best Protected Global Brands Report Reveals those that Demonstrate Robust Brand Strength and Protection

Clarivate plc (NYSE: CLVT) announced this week that it is buying ProQuest in a $5.3 billion deal. These are the details.

Why Clarivate Is Buying ProQuest For $5.3 Billion

LONDON, May 18, 2021 /PRNewswire/ -- Alt Legal, Inc., an award-winning IP docketing software company, and Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a partnership to integrate CompuMark™ international trademark data into the Alt Legal platform. Through this alliance, users of Alt Legal will gain access to CompuMark™ and its 186 trademark databases, covering all jurisdictions in the world.

Alt Legal Integrates Clarivate Data to Expand International Trademark Coverage

LONDON, May 17, 2021 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a definitive agreement to acquire ProQuest,  a leading global software, data and analytics provider to academic, research and national institutions, from Cambridge Information Group, a family-owned investment firm, and other partners including Atairos, for $5.3 billion, including refinancing of ProQuest debt. The consideration for the acquisition is approximately $4.0 billion in cash and $1.3 billion of equity.

Clarivate to Acquire ProQuest, Creating a Leading Global Provider of Mission Critical Information and Data-Driven Solutions for Science and Research

LONDON, May 13, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the Barclays Americas Select Franchise Conference on Wednesday, May 19, 2021 at 1:00 PM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.

Clarivate to Present at the Barclays Americas Select Franchise Conference on May 19, 2021

LONDON, May 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it reaffirmed its 2021 outlook for Adjusted revenues(1), Adjusted EBITDA(1), Adjusted EBITDA margin(1) and Adjusted free cash flow(1) and issued its 2021 Adjusted diluted EPS(1) outlook. Additionally, the Company filed its Form 10-Q for the period ending March 31, 2021 and an amendment to its Annual Report on Form 10-K for the period ending December 31, 2020.

Clarivate Reaffirms its 2021 Outlook and Provides 2021 Adjusted EPS Outlook

Winners of the annual award include ThedaCare Regional Medical Center, University of Iowa Hospitals & Clinics and Essentia Health LONDON, May 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the 2020 winners of the annual Revenue Cycle Awards, issued by Healthcare Business Insights to US based companies since 2012. The Revenue Cycle Awards recognize healthcare organizations for achieving outstanding performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.

Clarivate Announces 2020 Revenue Cycle Awards Recipients

LONDON, April 29, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the first quarter ended March 31, 2021.  First Quarter 2021 Financial Highlights Revenues of $428.4 million and Adjusted Revenues(1) of $431.5 million, both increased 78%.

Clarivate Reports First Quarter 2021 Results

Clarivate PLC (CLVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clarivate PLC (CLVT) Reports Next Week: Wall Street Expects Earnings Growth

Cortellis Deals Intelligence features new trends visualizations and predictive analytics supported by artificial intelligence  LONDON, April 22, 2021 /PRNewswire/ --  Clarivate Plc  (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis Deals Intelligence, a leading industry source of life science deals information. The new features include deal trend visualizations and predictive analytics, allowing users to confidently track the deal-making landscape and quickly understand the potential value of an asset.

Clarivate Releases Predictive Analytics to Help Fuel Life Sciences Deal Making Landscape

LONDON, April 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today published its first ever Annual Sustainability Report. The interactive report outlines the progress Clarivate made in 2020 in the areas of Governance, Environment, Colleagues and Community, and presents plans for 2021 as well as long term goals for the business.

Clarivate Releases Annual Sustainability Report Outlining 2020 Progress and Plans for the Future

LONDON, April 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the appointment of Julie Wilson as Chief People Officer (CPO). She replaces Andrea Degutis who retires after four years at the helm of Clarivate Human Resources.

Clarivate Appoints Julie Wilson as Chief People Officer and Announces Retirement of Andrea Degutis

LONDON, April 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report which explores the seismic shift of the research landscape in 19 countries across the Middle East, North Africa and Turkey (MENAT) region over recent decades. It presents an international success story, with the region's global share of research output quadrupling from 2% to 8% over the last 40 years, and papers from 22 million individual researchers identified within the region between 2008 and 2017.

Clarivate Global Research Report Outlines Rising Impact in MENAT Research Due to Strong International Collaboration

LONDON, March 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the BofA Securities 2021 Information Services Conference on Thursday, March 18, 2021 at 3:35 PM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.

News for Clarivate Plc Stock (CLVT)